@article{bellversanchis2026-41445192,
  author  = {Bellver-Sanchis, A. and Valle-Garcia, D. and Barbaraci, C. and Romero-Becerra, F. and Singh, R. K. and Jarne-Ferrer, J. and Vasilopoulou, F. and Irisarri, A. and others},
  title   = {{First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease}},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  year    = {2026},
  doi     = {10.1016/j.ymthe.2025.12.038},
  pmid    = {41445192},
  url     = {https://doi.org/10.1016/j.ymthe.2025.12.038}
}